Hanx Bio
Latest round
- Series B
Last raised
- May 2023
Total raised
- Undisclosed
Investors
- 5
About Hanx Bio
Founded in 2014, Hanx Bio specializes in biopharmaceuticals aimed at treating chronic illnesses and infectious diseases.Hanx Bio specializes in innovative biopharmaceutical products designed to address critical health challenges within the biotechnology sector. The company focuses on developing therapeutics that target specific diseases, leveraging advanced technologies to enhance efficacy and safety. Hanx Bio’s core product offerings include proprietary biologics and therapeutics aimed at treating chronic illnesses, autoimmune disorders, and infectious diseases. These products are meticulously designed to meet the needs of healthcare providers, patients, and research institutions, enhancing treatment outcomes and overall patient care.Hanx Bio generates revenue through a multifaceted transaction structure that includes direct sales to healthcare providers and B2B partnerships with pharmaceutical wholesalers. The company’s flagship products operate under a subscription and licensing model that offers clients continuous access to the latest therapeutic innovations, with structured agreements outlining pricing plans based on volume purchases and long-term partnerships.Hanx Bio's future growth strategy includes the launch of new therapeutics designed to address various health issues, with upcoming releases planned for late 2025. The company aims to expand its market presence in Europe and Southeast Asia by 2026.3 million from its IPO will support these initiatives, including the development of new products and geographic market expansion.
Who invested in Hanx Bio
5 investors across 2 rounds
See all investors in Hanx Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Hanx Bio
Who invested in Hanx Bio?
Hanx Bio has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hanx Bio raised?
Hanx Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Hanx Bio last raise money?
Hanx Bio's most recent round on record is a Series B, in May 2023.
What does Hanx Bio do?
Founded in 2014, Hanx Bio specializes in biopharmaceuticals aimed at treating chronic illnesses and infectious diseases.
Where is Hanx Bio headquartered?
Hanx Bio is headquartered in Wuhan, China.
Which VCs invest in companies like Hanx Bio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Hanx Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Hanx Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.